Patients who are unresponsive to 4–8 weeks' treatment with PPIs twice daily might have so-called refractory GERD. The first investigation these patients should undergo is upper endoscopy to ...

The following is a summary of “Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study,” ...

which might allow further disease control in patients with refractory myeloma. This case illustrates the restoration of chemosensitivity of myeloma cells when bortezomib is combined with ...

A recent study published in the December issue of the Journal of Gastroenterology and Hepatology highlights Vonoprazan's ...

The following is a summary of “Prognostic factors for refractory outcome in localizing TIO: experience in a tertiary center,” ...

Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...

Preliminary findings from the phase 1 trial showed that GCC19CART, a novel CAR T-cell therapy, demonstrated clinical ...

A panelist discusses how, despite recent advances in relapsed/refractory follicular lymphoma treatment, important unmet needs ...

RHI Magnesita, the leading global supplier of high-grade refractory products, systems and solutions, is pleased to announce the completion of the acqu ...